Most Recent

image: PCR Usage and Preferences

PCR Usage and Preferences

By | November 1, 2012

Quantitative real-time technology dominates the market today but digital PCR is on the rise.

0 Comments

image: Enter the Third Dimension

Enter the Third Dimension

By | September 1, 2012

Cell culture goes 3-D with devices that better mimic in vivo conditions.

2 Comments

image: Proteome Portraits

Proteome Portraits

By | August 1, 2012

Innovations in mass spectrometry are making quick, comprehensive, and easy proteome mapping more attainable than ever.

0 Comments

image: Move Over, Mother Nature

Move Over, Mother Nature

By | July 1, 2012

Synthetic biologists harness software to design genes and networks.

5 Comments

image: Microbiology Goes High-Tech

Microbiology Goes High-Tech

By | June 1, 2012

Out with toothpicks and pipettors; in with automation.

0 Comments

image: SPRead Your Antibody Capabilities

SPRead Your Antibody Capabilities

By | May 1, 2012

Using surface plasmon resonance to improve antibody detection and characterization: four case studies

0 Comments

image: Eyes on Cancer

Eyes on Cancer

By | April 1, 2012

Techniques for watching tumors do their thing

4 Comments

image: Live and In Color

Live and In Color

By | April 1, 2012

How to track RNA in living cells

2 Comments

image: Little Squirts

Little Squirts

By | February 1, 2012

A road map to liquid-handling solutions on the market

0 Comments

image: Learning to Become a Tree Hugger

Learning to Become a Tree Hugger

By | August 1, 2011

A guide to free software for constructing and assessing species relationships

0 Comments

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  4. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

RayBiotech